What is Lifecore Biomedical, Inc.'s long-term debt?

Lifecore Biomedical, Inc. (LFCR) reported long-term debt of $148.74M in Q1 2026.

What is the long-term trend for Lifecore Biomedical, Inc.'s long-term debt?

Over 4 years (2021 to 2026), Lifecore Biomedical, Inc.'s long-term debt has grown at a -2.5% compound annual growth rate (CAGR), from $164.9M to $148.74M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Lifecore Biomedical, Inc. LFCR Long-Term Debt

Long-Term Debt at other companies

Thermo Fisher ScientificTMO

$42.95B+26.4%

ADMA BiologicsADMA

$193.58M—

Biodesix, Inc.BDSX

$46.49M+26.7%

ClearPoint NeuroCLPT

$49.64M—

Charles River LaboratoriesCRL

$2.66B+6.1%

West Pharmaceutical ServicesWST

$202.8M+0.1%

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebt.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s long-term debt?: Lifecore Biomedical, Inc. (LFCR) reported long-term debt of $148.74M in Q1 2026.
What is the long-term trend for Lifecore Biomedical, Inc.'s long-term debt?: Over 4 years (2021 to 2026), Lifecore Biomedical, Inc.'s long-term debt has grown at a -2.5% compound annual growth rate (CAGR), from $164.9M to $148.74M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.